Called Zmapp, the three companies say the drug was first identified in January of this year. According to Mapp's website, the Ebola drug is "a cocktail" of monoclonal antibodies which had previously been tested on monkeys.

In a joint statement, the companies said, "As such, very little of the drug is currently available. Any decision to use an experimental drug in a patient would be a decision made by the treating physician under the regulatory guidelines of the FDA. Mapp and its partners are cooperation with appropriate government agencies to increase production as quickly as possible."

Literally days before Dr. Brantly and Writebol were stricken with Ebola, Mapp published a news release announcing an exclusive, worldwide license to their drug. "This license," said Jeffrey Turner, President and CEO of Defyrus, "places our ZMAb technology in the hands of experienced antibody manufacturers with specific regulatory expertise and funding. We share a joint vision with LeafBio to deliver an effective treatment for Ebola virus infection on a cost effective basis globally."

According to a press release earlier this year, in March, the National Institutes of Health (NIH) awarded a five-year grant of up to $28 million to establish a new center for excellence to find the drug.

Erica Ollmann Saphire, a professor at Scripps Research Institute was quoted as saying the efforts are "a global collaboration."

For decades, the press release noted, scientists thought no antibodies were effective against the Ebola virus, but in 2012, research from the US Army Medical Research Institute of Infectious Diseases showed that a mix of antibodies can stop the virus. Other labs around the world were simultaneously testing other such antibody cocktails with success.

Antibodies are currently thought to be the best strategy for treating rare and deadly viruses such as Ebola because they are effective even a couple of days after exposure, a time period during which a person could be airlifted to a hospital for treatment.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

President Trump Posts a Couple Christian, Prophetic Videos on His Truth Social Account

Mount Rushmore's Independence Day Fireworks Are Back

Young Families Flock to Red States as Blue States Lose Children, Data Shows

Study: Trans Shooters Commit 'Disproportionate Shares of Mass Public and Active Shooting Attacks'

Karoline Leavitt Busts Democrats' 'Huge Myth' that SAVE America Act Hurts Married Women's Ability to Vote [Video]

Daycares Under Microscope as Prosecutors Stamp Out Fraud after Minnesota Firestorm

The Fate of Iran's National Women's Football Team Took a Deceptive Turn at the Last Minute; What Will Happen to Them?

US Strikes 16 Iranian Mine-Laying Boats Near Strait of Hormuz: Pentagon [Video]

ICE Houston Announces Arrests of over 400 Illegal Immigrants Charged With or Convicted of Child Sex Offenses in 2025

4 Ways Christians Can Pray for the Situation in Iran

New Media Network Combats Anti-American Spin by Featuring Veterans, Law Enforcement

South Dakota Supreme Court Rules 'Transgender' Individuals Can't Change Birth Certificates

Evil: Oregon Democrats Block Bill Requiring Medical Care for Babies Born Alive after Abortions

Oil Prices Dip as Trump Says Iran Conflict Is 'Ahead of Schedule'

3-Hour Airport Security Lines, TSA Working Without Pay during Democrat Gov Shutdown

Democrats Slammed for Shutting Down DHS amid Terrorism Threats

Nation on High Alert after NYC Attack, as Suspects Aligned with Islamic State; Meanwhile Dems Continue Shutdown of Homeland Security

Evangelical Leaders Return to Oval Office to Pray over Trump

Terrorists Transformed into Evangelists: YWAM Reports Powerful Stories of Redemption in Nigeria

Jesse Jackson's Democrat Son CALLS OUT Obama, Biden, and Clinton for Politicizing His Father's Funeral: They 'Do Not Know Jesse Jackson'